Most Recent Funding
$1.6 Million on June 11, 2011 / Undisclosed Round
Headquarters:
Cambridge
Description:
Phico Therapeutics is developing a unique antibiotic technology to destroy multi-drug resistant bacteria in the human anatomy.
Categories:
Biotechnology
Website:
http://www.phicotherapeutics.co.uk

Company Details

Update

Phico Therapeutics is developing a unique antibiotic technology to address one the most urgent challenges facing medicine today – how to destroy multi-drug resistant bacteria, the so-called “superbugs”.

Phico’s patented platform utilises an antibacterial protein, SASP to inactivate bacterial DNA and cause rapid destruction of target bacteria. SASPject™ is a new class of antibiotic which could provide many advantages over conventional antibiotic classes.

Funding Rounds (1) - $1.6M

Update

Offices/Locations (1)

Update
  • Office

    Babraham Research Campus

    Babraham

    Cambridge, CB22 3AT

    GBR

Images (1)

Update
  • Acd7ac69a170351df404551e5ecfab3c